Fingerprint
Dive into the research topics of 'Eribulin plus pembrolizumab in patients with metastatic triple-negative breast cancer (ENHANCE 1): A phase Ib/II study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eribulin plus pembrolizumab in patients with metastatic triple-negative breast cancer (ENHANCE 1): A phase Ib/II study
Sara M. Tolaney, Kevin Kalinsky, Virginia G. Kaklamani, David R. D'Adamo, Gursel Aktan, Michaela L. Tsai, Ruth M. O'Regan, Peter A. Kaufman, Sharon T. Wilks, Eleni Andreopoulou, Debra A. Patt, Yuan Yuan, Grace Wang, Claudio Savulsky, Dongyuan Xing, Ella Kleynerman, Vassiliki Karantza, Sami Diab
Research output: Contribution to journal › Article › peer-review